Richard Kim

Richard’s experience includes representing:

IPOs and Direct Listings

• Airbnb in its US$3.8 billion IPO
• Amplitude in its direct listing
• Annexon in its US$287 million IPO
• Aratana Therapeutics in its US$39 million IPO and several subsequent public offerings
• BIND Therapeutics in its US$76 million IPO and subsequent public offerings
• BofA Securities in Janux Therapeutics’ US$222 million IPO
• Goldman Sachs in PMV Pharmaceuticals’ US$243 million IPO
• Jefferies in Reneo Pharmaceuticals’ US$93 million IPO
• JP Morgan, BofA Merrill Lynch, Goldman Sachs, William Blair, and Cantor Fitzgerald in Glaukos’ US$124 million IPO
• JP Morgan, Leerink Partners, William Blair, and Stifel in Inogen’s US$72 million IPO
• Omada Health in its IPO
• Piper Jaffray, Stifel, Leerink Partners, and William Blair in Sientra’s US$86 million IPO
• UBS Investment Bank, Canaccord Genuity, Stifel, and BTIG in Obalon Therapeutics' US$75 million IPO

Follow-On and Secondary Offerings

• BofA Merrill Lynch, JP Morgan, Morgan Stanley, Barclays, and Deutsche Bank Securities in BioMarin Pharmaceutical’s US$911 million follow-on offering
• BofA Securities, Jefferies, SVB Securities, Evercore ISI, and Guggenheim Securities in Vaxcyte’s US$600 million public offering
• Cantor Fitzgerald in Corium International’s US$20 million follow-on offering 
• Jefferies, Leerink Partners, and Wells Fargo Securities in Immune Design’s US$32 million follow-on offering
• JP Morgan, Cowen, Stifel, Wells Fargo Securities, and SunTrust Robinson Humphrey in Array Biopharma’s US$132 million follow-on offering of Array Biopharma
• Piper Jaffray and William Blair in LDR’s US$92 million follow-on offering of LDR
• Puma Biotechnology on several public offerings 

Debt Offerings

• Airbnb in its US$2 billion convertible senior notes offering
• AMD in its US$1 billion senior notes offering
• Eventbrite in its:
  • US$150 million convertible senior notes offering
  • US$212 million convertible senior notes offering